TransMedics Group, Inc. - COM (TMDX)

Historical Portfolio Holders from Q1 2019 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
33.6M
Holdings value Q2 2024
$5.06B
Value change Q2 2024
+$90.8M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
326
Number of buys Q2 2024
193
Number of sells Q2 2024
-137
Average buys Q2 2024 %
+0.004%
Average sells Q2 2024 %
-0.005%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 81.3K $12.8M +$6.09M $157.00 5
2024 Q2 33.6M $5.06B +$90.8M $150.62 330
2024 Q1 34M $2.51B -$71.4M $73.94 250
2023 Q4 34.9M $2.76B -$4.19M $78.93 243
2023 Q3 34.9M $1.91B +$75M $54.75 219
2023 Q2 32.5M $2.73B +$227M $83.98 239
2023 Q1 29.9M $2.26B +$69.3M $75.73 221
2022 Q4 29M $1.79B +$37.3M $61.72 196
2022 Q3 28.3M $1.18B +$229M $41.74 175
2022 Q2 22.9M $719M +$66.8M $31.45 130
2022 Q1 20.8M $561M +$24.7M $26.94 108
2021 Q4 20.1M $385M +$27.4M $19.16 116
2021 Q3 19.2M $636M +$13.3M $33.09 119
2021 Q2 18.8M $623M +$1.14M $33.18 118
2021 Q1 18.6M $773M -$21M $41.49 105
2020 Q4 21.3M $424M -$4.48M $19.90 68
2020 Q3 20.8M $287M +$6.19M $13.78 72
2020 Q2 20.2M $361M +$93M $17.92 68
2020 Q1 15.1M $182M -$2.05M $12.08 53
2019 Q4 15M $284M -$13.7K $19.01 59
2019 Q3 14.3M $337M +$4.71M $23.75 49
2019 Q2 11.2M $312M +$312M $28.99 59
2019 Q1 54 $2K $0 $37.04 1